Tandem Diabetes Care Inc  

(Public, NASDAQ:TNDM)   Watch this stock  
Find more results for Lonnie D. Morrison
-0.08 (-0.94%)
After Hours: 8.42 0.00 (0.00%)
Oct 6, 4:34PM EDT  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 8.14 - 8.66
52 week 8.14 - 17.98
Open 8.53
Vol / Avg. 0.00/212,739.00
Mkt cap 255.12M
P/E     -
Div/yield     -
EPS -3.12
Shares 30.01M
Beta     -
Inst. own 96%
Nov 2, 2015
Q3 2015 Tandem Diabetes Care Inc Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Sep 17, 2015
Tandem Diabetes Care Inc at Morgan Stanley Healthcare Conference
Sep 10, 2015
Tandem Diabetes Care Inc at Robert W Baird and Co Health Care Conference
Sep 9, 2015
Tandem Diabetes Care Inc Conference Call to Discuss FDA approval of the t:slim G4 Insulin Pump with CGM Integration. - Webcast
Aug 11, 2015
Tandem Diabetes Care Inc at Wedbush PacGrow Healthcare Conference
Jul 30, 2015
Q2 2015 Tandem Diabetes Care Inc Earnings Call - Webcast
Jul 30, 2015
Q2 2015 Tandem Diabetes Care Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin -124.37% -159.94%
Operating margin -118.88% -152.17%
EBITD margin - -143.32%
Return on average assets -52.85% -59.20%
Return on average equity -82.47% -93.50%
Employees 437 -
CDP Score - -


11045 Roselle St Ste 200
SAN DIEGO, CA 92121-1231
United States - Map
+1-858-3666900 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Tandem Diabetes Care, Inc. is a medical device company engaged in designing, developing and commercializing products for people with insulin-dependent diabetes. The Company's products include t:slim Insulin Delivery System (t:slim) and t:flex Insulin Delivery System (t:flex). The t:slim consists of the t:slim pump, its 300-unit disposable insulin cartridge and an infusion set. The t:flex consists of the t:flex pump, its 480-unit disposable insulin cartridge and an infusion set. The Company's technology platform features Micro-Delivery Technology, a miniaturized pumping mechanism, which draws insulin from a flexible bag within the pump's cartridge rather than relying on a syringe and plunger mechanism.

Officers and directors

Lonnie M. Smith Independent Chairman of the Board
Age: 70
Bio & Compensation  - Reuters
Kim D. Blickenstaff President, Chief Executive Officer, Board Member
Age: 62
Bio & Compensation  - Reuters
John Cajigas Chief Financial Officer, Treasurer
Age: 47
Bio & Compensation  - Reuters
John F. Sheridan Chief Operating Officer, Executive Vice President
Age: 59
Bio & Compensation  - Reuters
Robert B Anacone Executive Vice President, Chief Commercial Officer
Age: 64
Bio & Compensation  - Reuters
Susan M. Morrison Chief Administrative Officer
Age: 35
Bio & Compensation  - Reuters
David B. Berger Esq. General Counsel, Corporate Secretary
Age: 45
Bio & Compensation  - Reuters
Dick P. Allen Independent Director
Age: 70
Bio & Compensation  - Reuters
Edward L. Cahill Independent Director
Age: 61
Bio & Compensation  - Reuters
Fred E. Cohen Ph.D., M.D. Independent Director
Age: 58
Bio & Compensation  - Reuters